Nervive, Inc. Company
Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury. Founded in 2013, Nervive is headquartered in Akron, Ohio.
Total Funding:
$3.6M
Headquarters:
Akron, Ohio, United States
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Technology:
NeuroTech
Investors Number:
3
Founded Date:
2013-12-31
Industry:
Health Care, Medical, Wellness